In a subsequent infection, the pre-existing heterologous antibodies form complexes with the new infecting virus serotype, but do not neutralize the new virus
In a subsequent infection with a different virus serotype,
the pre-existing heterologous antibodies form complexes with
the new virus, but these heterologous antibodies do not
neutralize the new serotype.